LONDON BROKER RATINGS: Bernstein reinitiates Convatec at 'outperform'
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More
| Price | 172.20p on 06-02-2026 at 19:40:08 |
|---|---|
| Change | -0.80p -0.46% |
| Buy | 172.80p |
| Sell | 172.40p |
| Last Trade: | Sell 602.00 at 172.60p |
| Day's Volume: | 1,388,392 |
| Last Close: | 172.20p |
| Open: | 177.00p |
| ISIN: | GB0004657408 |
| Day's Range | 171.20p - 177.00p |
| 52wk Range: | 110.00p - 177.00p |
| Market Capitalisation: | £2.18b |
| VWAP: | 172.56488p |
| Shares in Issue: | 1.27b |
Mitie (MTO) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 602 | 172.60p | Automatic Execution |
16:27:55 - 06-Feb-26 |
| Sell* | 1,763 | 172.60p | Automatic Execution |
16:27:55 - 06-Feb-26 |
| Buy* | 76 | 172.80p | SI Trade |
16:27:46 - 06-Feb-26 |
| Sell* | 9 | 172.60p | SI Trade |
16:26:41 - 06-Feb-26 |
| Buy* | 925 | 172.80p | Automatic Execution |
16:22:56 - 06-Feb-26 |
| Buy* | 1,786 | 172.80p | Automatic Execution |
16:22:56 - 06-Feb-26 |
| Buy* | 435 | 172.80p | Automatic Execution |
16:22:56 - 06-Feb-26 |
| Buy* | 297 | 172.80p | Automatic Execution |
16:22:56 - 06-Feb-26 |
| Buy* | 4,286 | 172.80p | Automatic Execution |
16:22:56 - 06-Feb-26 |
| Buy* | 790 | 172.80p | Automatic Execution |
16:22:56 - 06-Feb-26 |
Mitie (MTO) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 5th Feb 2026 7:00 am | RNS | Transaction in Own Shares |
| 4th Feb 2026 7:00 am | RNS | Transaction in Own Shares |
| 3rd Feb 2026 7:00 am | RNS | Transaction in Own Shares |
| 2nd Feb 2026 4:30 pm | RNS | Total Voting Rights |
| 2nd Feb 2026 7:00 am | RNS | Transaction in Own Shares |
| 30th Jan 2026 7:00 am | RNS | Transaction in Own Shares |
| 29th Jan 2026 7:00 am | RNS | Transaction in Own Shares |
| 28th Jan 2026 7:00 am | RNS | Transaction in Own Shares |
| 27th Jan 2026 7:05 am | RNS | Transaction in Own Shares |
| 27th Jan 2026 7:00 am | RNS | Q3 FY26 Trading Update |